摘要
科技政策体现了不同集团的利益差别,由于不同的利益主体之间的竞争、权衡和妥协,科技政策必然成为它们利益博弈和协调的产物。本文以美国胚胎干细胞研究的政策演变为例,探讨了政策演变背后三个重要利益主体(国家、政党和民众)的利益诉求状况,特别对民众主体在科技政策制定中缺乏话语权的问题进行了反思。
Science and technology policy represents different interests among different groups. As a result of competition and compromise existing in different interest groups,science and technology policy is an outcome of the game between the different stakeholders.Based on the evolution of U.S. policy on embryonic stem cell research,paper reveals the different demands of three main interest stakeholders(country,political parties and general public),especially makes a reflection on that the general public is in a relatively weak positioa
出处
《自然辩证法通讯》
CSSCI
北大核心
2010年第5期60-65,共6页
Journal of Dialectics of Nature
基金
中国科协调研课题"科技前沿的伦理问题研究"的阶段性成果
项目编号:2009ZCYJ04-A
关键词
科技政策
利益主体
干细胞研究
政策演变
民众参与
Science and technology policy
Interests subjects
Stem cell research
Public participation